Coronary Artery Disease

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of hypertensive disorders of pregnancy had nearly double the risk of subsequent coronary artery disease compared to age- and parity-matched women with normotensive pregnancies.

Effect: decline; HR 1.89; CI: 95% CI 1.26-2.82

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33